These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 11503680)

  • 1. Medical devices; labeling for menstrual tampon for the "ultra" absorbency. Food and Drug Administration, HHS. Final rule.
    Fed Regist; 2000 Oct; 65(202):62282-5. PubMed ID: 11503680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medical devices; labeling for menstrual tampons; ranges of absorbency, change from "junior" to "light." Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2004 Aug; 69(164):52170-1. PubMed ID: 15329983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amended economic impact analysis of final rule requiring use of labeling on natural rubber containing devices--FDA. Final rule; amended economic analysis statement.
    Fed Regist; 1998 Sep; 63(183):50660-704. PubMed ID: 10185803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amended economic impact analysis of final rule requiring use of labeling on natural rubber containing devices--FDA. Final rule; amended economic analysis statement.
    Fed Regist; 1998 Jun; 63(104):29552-90. PubMed ID: 10179863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amended economic impact analysis of final rule requiring use of labeling on natural rubber containing devices--FDA. Final rule; amended economic analysis statement.
    Fed Regist; 1998 Aug; 63(168):46171-4. PubMed ID: 10182698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topical antifungal drug products for over-the-counter human use; amendment of final monograph. Food and Drug Administration, HHS. Final rule.
    Fed Regist; 2000 Aug; 65(168):52302-5. PubMed ID: 11067736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medical devices; device tracking--FDA. Final rule; notification of status under the Safe Medical Devices Act; confirmation of effective date.
    Fed Regist; 1992 May; 57(104):22966-70. PubMed ID: 10171013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical safety assessment of an ultra absorbency menstrual tampon.
    Hochwalt AE; Jones MB; Meyer SJ
    J Womens Health (Larchmt); 2010 Feb; 19(2):273-8. PubMed ID: 20109120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sunscreen drug products for over-the-counter human use; final monograph. Food and Drug Administration, HHS. Final rule.
    Fed Regist; 1999 May; 64(98):27666-93. PubMed ID: 10558542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medical devices; hearing aids; technical data amendments. Direct final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2008 Jun; 73(106):31358-60. PubMed ID: 18677822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medical devices; exemption from premarket notification and reserved devices; class I. Food and Drug Administration, HHS. Final rule.
    Fed Regist; 2000 Jan; 65(10):2296-323. PubMed ID: 11010655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Over-the-counter human drugs; labeling requirements. Food and Drug Administration, HHS. Final rule.
    Fed Regist; 1999 Mar; 64(51):13254-303. PubMed ID: 10557606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dissemination of information on unapproved/new uses for marketed drugs, biologics, and devices--FDA. Final rule.
    Fed Regist; 1998 Nov; 63(224):64556-88. PubMed ID: 10339052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antidiarrheal drug products for over-the-counter human use; final monograph. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2003 Apr; 68(74):18869-82. PubMed ID: 12701600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medical devices; designation of special control for eight surgical suture devices. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2003 Jun; 68(106):32983-5. PubMed ID: 12784826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural rubber-containing medical devices; user labeling--FDA. Final rule.
    Fed Regist; 1997 Sep; 62(189):51021-30. PubMed ID: 10175218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cold, cough, allergy, bronchodilator, and antiasthmatic drug products for over-the-counter human use; amendment of final monograph for OTC antitussive drug products. Food and Drug Administration, HHS. Final rule.
    Fed Regist; 2000 Aug; 65(148):46864-8. PubMed ID: 11067707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulations restricting the sale and distribution of cigarettes and smokeless tobacco to protect children and adolescents. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2010 Mar; 75(53):13225-32. PubMed ID: 20383919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delegations of authority and organization; Office of the Commissioner--FDA. Final rule.
    Fed Regist; 1991 Nov; 56(225):58758. PubMed ID: 10115698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Revision to requirements for licensed Anti-Human Globulin and Blood Grouping Reagents. Food and Drug Administration, HHS. Direct final rule.
    Fed Regist; 2000 Dec; 65(239):77497-9. PubMed ID: 11503726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.